CHICAGO TRUST Co NA Cuts Position in Colgate-Palmolive (NYSE:CL)

CHICAGO TRUST Co NA reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 6.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,582 shares of the company’s stock after selling 400 shares during the period. CHICAGO TRUST Co NA’s holdings in Colgate-Palmolive were worth $507,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of CL. Capital Investment Advisors LLC grew its stake in Colgate-Palmolive by 2.5% during the 4th quarter. Capital Investment Advisors LLC now owns 9,634 shares of the company’s stock worth $876,000 after purchasing an additional 238 shares in the last quarter. Brookstone Capital Management grew its position in shares of Colgate-Palmolive by 12.0% in the 4th quarter. Brookstone Capital Management now owns 19,455 shares of the company’s stock valued at $1,769,000 after buying an additional 2,089 shares during the last quarter. Trust Co. of Toledo NA OH increased its position in shares of Colgate-Palmolive by 3.8% during the fourth quarter. Trust Co. of Toledo NA OH now owns 18,096 shares of the company’s stock worth $1,645,000 after purchasing an additional 663 shares in the last quarter. Fiduciary Alliance LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth approximately $4,066,000. Finally, Czech National Bank raised its position in Colgate-Palmolive by 6.4% in the 4th quarter. Czech National Bank now owns 177,145 shares of the company’s stock valued at $16,104,000 after purchasing an additional 10,696 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

NYSE CL opened at $87.02 on Tuesday. The business’s 50-day simple moving average is $92.49 and its 200-day simple moving average is $97.98. The firm has a market capitalization of $71.10 billion, a P/E ratio of 24.93, a P/E/G ratio of 3.31 and a beta of 0.44. Colgate-Palmolive has a 1-year low of $79.69 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.30%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 57.31%.

Insider Activity

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.34% of the company’s stock.

Wall Street Analysts Forecast Growth

CL has been the subject of several analyst reports. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price objective for the company from $105.00 to $101.00 in a research note on Monday, October 28th. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. TD Cowen dropped their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Wells Fargo & Company decreased their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Finally, JPMorgan Chase & Co. upped their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and an average price target of $103.63.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.